Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone in older newly diagnosed AML
NCT03609060Phase 2Active, not recruiting
- Sponsor
- French Innovative Leukemia Organisation
- Start
- Aug 2018
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in acute myeloid leukemia (AML), sponsored by French Innovative Leukemia Organisation. Started Aug 2018; status: active, not recruiting.
02
Drugs
dexamethasone
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT03609060.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03609060.